193 related articles for article (PubMed ID: 11488722)
21. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.
Blom JH; van Poppel H; Maréchal JM; Jacqmin D; Schröder FH; de Prijck L; Sylvester R;
Eur Urol; 2009 Jan; 55(1):28-34. PubMed ID: 18848382
[TBL] [Abstract][Full Text] [Related]
22. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma.
Simmons MN; Kaouk J; Gill IS; Fergany A
Urology; 2007 Jul; 70(1):43-6. PubMed ID: 17656205
[TBL] [Abstract][Full Text] [Related]
24. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
Wei Y; Wang M; Jin Y; Zhou C; Lyu J
World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
[TBL] [Abstract][Full Text] [Related]
25. Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection.
Babaian KN; Kim DY; Kenney PA; Wood CG; Wong J; Sanchez C; Fang JE; Gerber JA; Didic A; Wahab A; Golla V; Torres C; Tamboli P; Qiao W; Matin SF; Wood CG; Karam JA
J Urol; 2015 Apr; 193(4):1101-7. PubMed ID: 25390078
[TBL] [Abstract][Full Text] [Related]
26. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
[TBL] [Abstract][Full Text] [Related]
27. Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy.
Kuusk T; Klatte T; Zondervan P; Lagerveld B; Graafland N; Hendricksen K; Capitanio U; Minervini A; Stewart GD; Ljungberg B; Horenblas S; Bex A
World J Urol; 2021 Sep; 39(9):3377-3383. PubMed ID: 33634323
[TBL] [Abstract][Full Text] [Related]
28. The role of lymph node dissection in renal cell carcinoma.
Chapin BF; Delacroix SE; Wood CG
Int J Clin Oncol; 2011 Jun; 16(3):186-94. PubMed ID: 21523561
[TBL] [Abstract][Full Text] [Related]
29. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
[TBL] [Abstract][Full Text] [Related]
30. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
[TBL] [Abstract][Full Text] [Related]
31. Role of lymphadenectomy in the treatment of renal cell carcinoma.
Phillips E; Messing EM
Urology; 1993 Jan; 41(1):9-15. PubMed ID: 8420090
[TBL] [Abstract][Full Text] [Related]
32. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
[TBL] [Abstract][Full Text] [Related]
33. Influence of lymph node dissection in patients undergoing radical nephrectomy for non-metastatic renal cell carcinoma: a systematic review and meta-analysis.
Luo X; Li JX; Liu YT; Zou G; Yao WX; Qing GQ; Yang RL; Ye XY; Facchini G; Rossetti S
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6079-6090. PubMed ID: 31364109
[TBL] [Abstract][Full Text] [Related]
34. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
[TBL] [Abstract][Full Text] [Related]
35. [Tumor size and regional lymph node metastasis in patients with M0 renal cell carcinoma: analysis in those having regional lymph node dissection].
Hashimoto K; Hisasue S; Yanase M; Takahashi A; Hisataki T; Kitamura H; Masumori N; Itoh N; Tsukamoto T
Hinyokika Kiyo; 2005 Sep; 51(9):621-5. PubMed ID: 16229376
[TBL] [Abstract][Full Text] [Related]
36. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
Tachibana I; Vasquez R; Mahmoud M; Kern SQ; Patel RS; King J; Adra N; Boris RS; Cary C; Rice KR
Urol Oncol; 2022 Nov; 40(11):495.e11-495.e17. PubMed ID: 36154800
[TBL] [Abstract][Full Text] [Related]
37. Lymph Node Dissection for Small Renal Masses.
Blute ML; Gupta M; Crispen PL
Urol Clin North Am; 2017 May; 44(2):269-274. PubMed ID: 28411918
[TBL] [Abstract][Full Text] [Related]
38. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates.
Crispen PL; Breau RH; Allmer C; Lohse CM; Cheville JC; Leibovich BC; Blute ML
Eur Urol; 2011 Jan; 59(1):18-23. PubMed ID: 20933322
[TBL] [Abstract][Full Text] [Related]
39. The role of lymph node dissection in the contemporary management of renal cell carcinoma: A critical appraisal of the evidence.
Brito J; Gershman B
Urol Oncol; 2017 Nov; 35(11):623-626. PubMed ID: 28712789
[TBL] [Abstract][Full Text] [Related]
40. Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
Delacroix SE; Chapin BF; Chen JJ; Nogueras-Gonzalez GM; Tamboli P; Matin SF; Wood CG
J Urol; 2011 Oct; 186(4):1236-41. PubMed ID: 21849197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
